טוען...
Measuring Disease Progression in Primary Lateral Sclerosis
Quantitative measures of disease severity are essential outcome measures for clinical trials. The slow progression of disease in primary lateral sclerosis (PLS) requires clinical measures that are sensitive to changes occurring within the time frame of a clinical trial. Proposed clinical outcome mea...
שמור ב:
| הוצא לאור ב: | Amyotroph Lateral Scler Frontotemporal Degener |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7899091/ https://ncbi.nlm.nih.gov/pubmed/33602016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678421.2020.1837179 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|